The treatment of primary intraocular malignancy
β Scribed by Luther W. Brady; Arnold M. Markoe; Beatriz E. Amendola; Ulf L. Karlsson; Bizhan Micaily; Jerry A. Shields; James J. Augsburger
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 774 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Topotecan activity was evaluated for the treatment of malignant glioma. ## METHODS. Sixty-three patients with newly diagnosed (n Ο 25) or recurrent (n Ο 38) malignant glioma were treated with topotecan {AU: Please verify all dosages here and throughout text.}at a dose of 2.6 mg/m
A case of primary hemangioendothelioma is presented. Following autodearterialization, the patient received 5-fluorouracil orally and total hepatic radiation. To date, 30 months later, he remains alive and active with residual hepatic defect on liver scan, but no indication of progression of disease.
The author's experience in the diagnosis and treatment of primary malignant bone tumors (700 cases) is reviewed, together with the experience of the staff a t T h e University of Texas M. D. Anderson Hospital and Tumor Institute, to evaluate various approaches to diagnosis and treatment, and to dete